1. Volume 74, Issue 12, Pages 1588-1595 (December 2008)
Ferric gluconate treatment provides cost savings in patients with high ferritin and low transferrin saturation 
Laura T. Pizzi, Thomas J. Bunz, Daniel W. Coyne, David S. Goldfarb, Ajay K. Singh 
Kidney International 
Volume 74, Issue 12, Pages (December 2008)
DOI: /ki
Copyright © 2008 International Society of Nephrology Terms and Conditions

2. Figure 1
Results of the probabilistic sensitivity analysis, showing the incremental cost-effectiveness scatter plot of SFGC+epoetin versus epoetin alone based on 1 million random iterations of the cost-effectiveness model (% indicates the proportion of points in each quadrant
Kidney International  , DOI: ( /ki )
Copyright © 2008 International Society of Nephrology Terms and Conditions

3. Figure 2
Decision tree framework, showing DRIVE study arms, which served as the basis for the economic model.
Kidney International  , DOI: ( /ki )
Copyright © 2008 International Society of Nephrology Terms and Conditions

4. Kidney International 2008 74, 1588-1595DOI: (10.1038/ki.2008.489)
Copyright © 2008 International Society of Nephrology Terms and Conditions

5. Kidney International 2008 74, 1588-1595DOI: (10.1038/ki.2008.489)
Copyright © 2008 International Society of Nephrology Terms and Conditions